Fig. 6From: miR-34a mimic or pre-mir-34a, which is the better option for cancer therapy? KatoIII as a model to study miRNA action in human gastric cancer cellsThe effect of stable transfection of pre-mir-34a on the apoptosis rate. The flow cytometric assessments using FITC- conjugated Annexin V/PI (a) or PE-conjugated Annexin V/7AAD (b) demonstrated an increase of ~ 3.5% in apoptotic cells of KatoIII-pGFPC1-34a cells compared with KatoIII-pGFPC1-empty cellsBack to article page